| 000 | 01614 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518021746.0 | ||
| 264 | 0 | _c20190911 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1439-0272 | ||
| 024 | 7 |
_a10.1111/and.13240 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYilmaz, Enis | |
| 245 | 0 | 0 |
_aEffects of hydrogen sulphide donor, sodium hydrosulphide treatment on the erectile dysfunction in L-NAME-induced hypertensive rats. _h[electronic resource] |
| 260 |
_bAndrologia _cJun 2019 |
||
| 300 |
_ae13240 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCystathionine gamma-Lyase _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aErectile Dysfunction _xdrug therapy |
| 650 | 0 | 4 |
_aFibrosis _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Sulfide _xpharmacology |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xtoxicity |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
| 650 | 0 | 4 |
_aPenile Erection _xdrug effects |
| 650 | 0 | 4 |
_aPenis _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSulfides _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKaya-Sezginer, Ecem | |
| 700 | 1 | _aYilmaz-Oral, Didem | |
| 700 | 1 | _aCengiz, Tugba | |
| 700 | 1 | _aBayatli, Nur | |
| 700 | 1 | _aGur, Serap | |
| 773 | 0 |
_tAndrologia _gvol. 51 _gno. 5 _gp. e13240 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/and.13240 _zAvailable from publisher's website |
| 999 |
_c29316309 _d29316309 |
||